Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 17, Issue 4, Pages -Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11882-017-0688-z
Keywords
Severe asthma; Childhood asthma; Biomarkers; Biologic therapy; Pharmacologic therapy
Categories
Funding
- AstraZeneca
- Boehringer Ingelheim
- Circassia
- Genentech Novartis
- Teva
Ask authors/readers for more resources
Purpose of Review The aim of this study is to characterize, diagnose, evaluate, and treat severe childhood asthma. Recent Findings Understanding the occurrence of the physiologic and clinical presentations of childhood severe asthma, the treatment and response may be predicted by biomarkers, but the patient's response is highly variable. Summary The onset of severe asthma occurs early and is primarily predicted by severity of viral infection and coexistence of the atopic state.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
